CN Stock MarketDetailed Quotes
688606 Hangzhou Alltest Biotech
Watchlist
75.97
-3.83-4.80%
Market Closed 12/08 15:00 CST
80.39High75.97Low15.90KlotVolume
79.67Open79.80Pre Close124.78MTurnover4.24%Turnover RatioLossP/E (TTM)6.02BMarket Cap89.6752wk High5.09P/E (Static)79.28MShares46.0252wk Low1.61P/B2.85BFloat Cap149.94Historical High95.76Limit Up37.46MShs Float46.02Historical Low63.84Limit Down5.54%Amplitude8.52KlotAsk6.76Dividend TTM78.49Avg Price8.75KlotBid8.89%Div YieldTTM100Lot Size
Hangzhou Alltest Biotech Key Stats
EPS
According to the latest financial report of Hangzhou Alltest Biotech, the latest earnings per share (TTM) for the company is 1.28. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Hangzhou Alltest Biotech's latest financial report to see how much their book value per share (BVPS) is currently at 47.26.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Hangzhou Alltest Biotech shows that the company's current ratio is 11.77, indicating healthy liquidity.
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Hangzhou Alltest Biotech, the quick ratio is 11.07, indicating that the company can meet its short-term debt obligations.
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Hangzhou Alltest Biotech? The latest ROE figure is 2.57%, indicating that the company has stable profitability.
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Hangzhou Alltest Biotech, the total asset return on investment (ROA) is 2.32%.
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Hangzhou Alltest Biotech's latest financial report to see how their gross margin is doing - currently at 47.91%.
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Hangzhou Alltest Biotech, the net profit margin is 18.08%, which is a good sign for its profitability.
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.